Archives

Regulatory Watch News

• 

  Fintel Alliance to expand after intelligence partnerships prove essential to fight financial crime

  Austrac

  May 12, 2025

  Joint efforts under AUSTRAC’s Fintel Alliance have led to significant law enforcement outcomes, prompting AUSTRAC to expand its successful intelligence partnership. Fintel Alliance is a world leading public-private partnership where members and law enforcement work together and share data in real time to target serious crime. AUSTRAC CEO, Brendan Thomas said the Intelligence Division’s Fintel Alliance has been so productive that the agency will now make its collaborative data analytics hub a central function going forward.

• 

  Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay $3.6M to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product

  US Department of Justice

  May 9, 2025

  The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) drug Lazanda for individuals who did not have breakthrough cancer pain.

• 

  Update to the UK Sanctions List: Russia Regime

  UK Government

  May 9, 2025

  Today, 9 May, the UK Government has sanctioned 101 ships, 5 individuals, and 4 entities under the Russia sanctions regime. This is the UK's largest package targeting Russia’s shadow fleet and its enablers.